Rozov Yadin insider trades
Rozov Yadin has filed 29 Form 4s with the SEC that we hold, for Dave Inc./DE (DAVE) (Director), Core Scientific, Inc./tx (CORZ) (Director), Oramed Pharmaceuticals INC. (ORMP) (Director) and MDWT (Director). Across all of them we count 6 purchases worth $1.7M and 17 sales worth $7.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 105,000 shares of Core Scientific, Inc./tx worth $1.9M, dated 2024-11-22. The first filing on our record is dated 2022-05-03 and the latest 2026-06-09.
Dave Inc./DE (DAVE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-04 | P, purchase reported on Form 4 | 12,941 | $82.8K | 2023-12-06 |
| 2024-03-07 | P, purchase reported on Form 4 | 800 | $29.8K | 2024-03-11 |
| 2025-06-04 | S, sale reported on Form 4 | 5,400 | $1.1M | 2025-06-05 |
| 2025-06-04 | S, sale reported on Form 4 | 100 | $20.8K | 2025-06-05 |
| 2025-09-04 | S, sale reported on Form 4 | 228 | $46.5K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 596 | $120.3K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 2,327 | $468.0K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 1,384 | $280.8K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 1,659 | $324.8K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 1,012 | $199.3K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 800 | $158.4K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 3,035 | $603.9K | 2025-09-05 |
| 2025-09-04 | S, sale reported on Form 4 | 3,619 | $723.4K | 2025-09-05 |
| 2025-09-12 | S, sale reported on Form 4 | 591 | $135.8K | 2025-09-12 |
| 2025-09-12 | S, sale reported on Form 4 | 2,462 | $561.1K | 2025-09-12 |
| 2025-09-12 | S, sale reported on Form 4 | 848 | $192.3K | 2025-09-12 |
| 2025-09-12 | S, sale reported on Form 4 | 3 | $676 | 2025-09-12 |
| 2025-09-12 | S, sale reported on Form 4 | 822 | $187.9K | 2025-09-12 |
Core Scientific, Inc./tx (CORZ)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-15 | P, purchase reported on Form 4 | 80,000 | $245.6K | 2024-03-18 |
| 2024-11-22 | S, sale reported on Form 4 | 105,000 | $1.9M | 2024-11-22 |
| 2025-05-28 | P, purchase reported on Form 4 | 110,000 | $1.2M | 2025-05-29 |
Oramed Pharmaceuticals INC. (ORMP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-03-13 | P, purchase reported on Form 4 | 20,000 | $39.2K | 2023-03-15 |
| 2023-03-14 | P, purchase reported on Form 4 | 50,000 | $102.5K | 2023-03-15 |
MDWT
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1921268) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms